Terumo Europe N.V. Enrolls First Patient in Clinical Trial of Nobori(TM) Drug-eluting Coronary Stent
Terumo Europe N.V. Enrolls First Patient in Clinical Trial of Nobori(TM) Drug-eluting Coronary Stent
About this item
Full title
Publisher
New York: PR Newswire Association LLC
Journal title
Language
English
Formats
Publication information
Publisher
New York: PR Newswire Association LLC
Subjects
More information
Scope and Contents
Contents
NOBORI 1 is a prospective, randomized clinical trial that will enroll 360 patients in 30 centres in Europe, Australia and Asia. The NOBORI 1 is an equivalency study that will compare Terumo's Nobori Biolimus A9(TM) drug- eluting stent to Boston Scientific's Taxus(TM) Express2(TM) drug-eluting stent in an un-proportional 2:1 design. The primary endp...
Alternative Titles
Full title
Terumo Europe N.V. Enrolls First Patient in Clinical Trial of Nobori(TM) Drug-eluting Coronary Stent
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_448446209
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_448446209
